← Leaderboards
Wei-Jun Qian
University Of Florida
$13,199,384
Attributed
$22,865,446
Total exposure
12
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.4M · FY2009–25$10M$7.5M$5M$2.5M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$33,168,948 · 14
By mechanism
U54$10,741,064 · 4
U01$9,571,983 · 4
R01$6,202,572 · 3
UC4$2,719,424 · 1
DP2$2,138,717 · 1
DP3$1,795,188 · 1
Top collaborators
- Clayton E Mathews14 shared
- Jon Jacobs8 shared
- Anna E Lokshin8 shared
- Martha L Campbell-Thompson6 shared
- Rohit N. Kulkarni6 shared
- Herbert M. Sauro5 shared
- H. Steven Wiley5 shared
- James Paul Carson4 shared
Most similar at University Of Florida
Same institution · by research overlap
- Desmond Arthur Schatz$16,657,017
- Clayton E Mathews$19,414,489
- David A Ostrov$2,196,734
- Christopher D Vulpe$12,444,096
- Cuong Q Nguyen$5,076,541
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsTechnologyBaseSamplingCellsMass Spectrum AnalysisMolecularExperimental StudyProteomicsReagentTissuesCommunitiesInterestResourcesComplexPlayCollaborationsLaboratoriesPost-Translational Protein ProcessingProtocols DocumentationPathway InteractionsInsulinInsightSuccess
Grant awards (43)
Robust Mass Spectrometric Protein/Peptide Assays for Type 1 Diabetes Clinical Applications$930,427
U01 · FY2025 · DK · contact PI
Discovery and Roles of In Situ Islet Neoantigens in Human Type 1 Diabetes$691,406
R01 · FY2025 · DK
PSP Omics Center of Acute to Chronic Pain Signatures$526,504
U54 · FY2025 · DA
Robust Mass Spectrometric Protein/Peptide Assays for Type 1 Diabetes Clinical Applications$949,078
U01 · FY2024 · DK · contact PI
Discovery and Roles of In Situ Islet Neoantigens in Human Type 1 Diabetes$696,346
R01 · FY2024 · DK
PSP Omics Center of Acute to Chronic Pain Signatures$536,927
U54 · FY2024 · DA
Multi-omic 3D tissue maps for a Human BioMolecular Atlas$1,947,288
U54 · FY2023 · DK · contact PI
Robust Mass Spectrometric Protein/Peptide Assays for Type 1 Diabetes Clinical Applications$982,617
U01 · FY2023 · DK · contact PI
Discovery and Roles of In Situ Islet Neoantigens in Human Type 1 Diabetes$715,709
R01 · FY2023 · DK
Reverse Sensitivity Analysis for Identifying Predictive Proteomics Signatures of Cancer$564,140
U01 · FY2023 · CA
Coordination Core$112,360
U54 · FY2023 · DK · contact PI
PSP Omics Center of Acute to Chronic Pain Signatures$99,799
U54 · FY2023 · DA
Multi-omic 3D tissue maps for a Human BioMolecular Atlas$1,211,401
U54 · FY2022 · DK · contact PI
Multiplex Mass Spectrometric Protein Assays for Precise Monitoring of the Pathophysiology of Obesity$743,932
U01 · FY2022 · DK · contact PI
Pathways and critical regulators of early beta-cell dysfunction in type 1 diabetes$732,134
R01 · FY2022 · DK · contact PI
PSP Omics Center of Acute to Chronic Pain Signatures$678,601
U54 · FY2022 · DA
Reverse Sensitivity Analysis for Identifying Predictive Proteomics Signatures of Cancer$573,846
U01 · FY2022 · CA
PSP Omics Center of Acute to Chronic Pain Signatures$500,000
U54 · FY2022 · DA
Multi-omic 3D tissue maps for a Human BioMolecular Atlas$249,994
U54 · FY2022 · DK · contact PI
Coordination Core$108,401
U54 · FY2022 · DK · contact PI
PSP Omics Center of Acute to Chronic Pain Signatures$1,375,166
U54 · FY2021 · DA
Multi-omic 3D tissue maps for a Human BioMolecular Atlas$985,463
U54 · FY2021 · DK · contact PI
Multiplex Mass Spectrometric Protein Assays for Precise Monitoring of the Pathophysiology of Obesity$752,834
U01 · FY2021 · DK · contact PI
Pathways and critical regulators of early beta-cell dysfunction in type 1 diabetes$740,135
R01 · FY2021 · DK · contact PI
Reverse Sensitivity Analysis for Identifying Predictive Proteomics Signatures of Cancer$597,684
U01 · FY2021 · CA
Integrated risk assessment and molecular characterization of pulmonary response to e-cigarette exposure$555,762
R01 · FY2021 · HL · contact PI
Coordination Core$108,400
U54 · FY2021 · DK · contact PI
PSP Omics Center of Acute to Chronic Pain Signatures$1,375,166
U54 · FY2020 · DA
Multiplex Mass Spectrometric Protein Assays for Precise Monitoring of the Pathophysiology of Obesity$755,569
U01 · FY2020 · DK · contact PI
Multi-omic 3D tissue maps for a Human BioMolecular Atlas$750,693
U54 · FY2020 · DK · contact PI
Pathways and critical regulators of early beta-cell dysfunction in type 1 diabetes$744,819
R01 · FY2020 · DK · contact PI
Reverse Sensitivity Analysis for Identifying Predictive Proteomics Signatures of Cancer$715,682
U01 · FY2020 · CA
Integrated risk assessment and molecular characterization of pulmonary response to e-cigarette exposure$576,908
R01 · FY2020 · HL · contact PI
Key Events in Modulation of Lung Infection Susceptibility by Nanomaterials$387,571
U01 · FY2020 · ES · contact PI
Coordination Core$108,401
U54 · FY2020 · DK · contact PI
Multiplex Mass Spectrometric Protein Assays for Precise Monitoring of the Pathophysiology of Obesity$1,010,255
U01 · FY2019 · DK · contact PI
Pathways and critical regulators of early beta-cell dysfunction in type 1 diabetes$749,353
R01 · FY2019 · DK · contact PI
Reverse Sensitivity Analysis for Identifying Predictive Proteomics Signatures of Cancer$608,348
U01 · FY2019 · CA
PSP Omics Center of Acute to Chronic Pain Signatures$66,500
U54 · FY2019 · DA
Serum protein biomarkers for predicting type 1 diabetes$1,795,188
DP3 · FY2016 · DK · contact PI
Regulatory Networks and Biomarkers of Beta-cell Dysfunction and Apoptosis$98,016
UC4 · FY2016 · DK · contact PI
Regulatory Networks and Biomarkers of Beta-cell Dysfunction and Apoptosis$2,621,408
UC4 · FY2014 · DK · contact PI
A Universal Multiplex Assay System for High-Throughput Clinical Applications$2,138,717
DP2 · FY2009 · OD · contact PI